Search Within

Genitourinary Oncology Service

  1. "Head and Neck Service"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (17)
  3. Research Letter (1)
Groups
  1. Department of Medicine (49)
  2. Head and Neck Service (49)
  3. Solid Tumor Oncology Division (49)
  4. Department of Pathology and Laboratory Medicine (24)
  5. GSK Faculty (23)
  6. Radiology, Department of (23)

More Groups

People
  1. David Pfister (30)
  2. Alan Ho (26)
  3. Matthew Fury (21)
  4. Eric Sherman (18)
  5. David Solit (16)
  6. Nancy Lee (14)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (3)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. International Journal of Radiation Oncology, Biology, Physics (6)
  3. Annals of Oncology (3)
  4. Cancer (3)
  5. Investigational New Drugs (3)
  6. Cancer Chemotherapy and Pharmacology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. Elsevier Inc. (6)
  3. Springer (5)
  4. Oxford University Press (4)
  5. American Association for Cancer Research (3)
  6. American Medical Association (3)

More Publishers

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • First-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in head and neck cancers: An additional cohort of the phase 1 SURPASS trial
    Meeting Abstract

    Ho, A.; Garcia-Consuegra, A.; Saro, J.; Sauer, A.; Cristiani, S.; Brophy, F. E.; Streets, S.; Norry, E.; Gillison, M.; Charlson, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
    Journal Article

    Valero, C.; Golkaram, M.; Vos, J. L.; Xu, B.; Fitzgerald, C.; Lee, M.; Kaplan, S.; Han, C. Y.; Pei, X.; Sarkar, R.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Provision of subspecialized expert oncology (SEO) opinions using Navya Cancer Data Model (NCDM), a technology-based platform: Prospective study to facilitate access to care
    Meeting Abstract

    Traina, T. A.; Kantoff, P. W.; Matasar, M. J.; Dunn, L.; Friedman, C. F.; Voss, M. H.; Seidman, A. D.; Cahlon, O.; Zauderer, M. G.; Manship, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of fibroblast growth factor receptor inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Harding, J. J.; Schram, A. M.; Canestraro, J.; Haggag-Lindgren, D.; Heinemann, M.; Kriplani, A.; Jhaveri, K.; Voss, M. H.; Bajorin, D.; more...
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • A phase 1b study of cetuximab and BYL719 (alpelisib) concurrent with intensity modulated radiation therapy in stage III-IVB head and neck squamous cell carcinoma
    Journal Article

    Dunn, L. A.; Riaz, N.; Fury, M. G.; McBride, S. M.; Michel, L.; Lee, N. Y.; Sherman, E. J.; Baxi, S. S.; Haque, S. S.; Katabi, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save